116 related articles for article (PubMed ID: 35363433)
1. Role of N6-methyladenosine RNA modification in the imbalanced inflammatory homeostasis of arsenic-induced skin lesions.
Yang F; Zhang A
Environ Toxicol; 2022 Aug; 37(8):1831-1839. PubMed ID: 35363433
[TBL] [Abstract][Full Text] [Related]
2. Involvement of METTL3 in arsenite-induced skin lesions by targeting the SOCS3/STAT3/Krt signaling pathway.
Yang F; Zhang A
Environ Pollut; 2023 Jan; 316(Pt 2):120634. PubMed ID: 36368553
[TBL] [Abstract][Full Text] [Related]
3. N
Zhao T; Sun D; Zhao M; Lai Y; Liu Y; Zhang Z
Environ Pollut; 2020 Apr; 259():113908. PubMed ID: 31931413
[TBL] [Abstract][Full Text] [Related]
4. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
Zhang X; Hao H; Ma L; Zhang Y; Hu X; Chen Z; Liu D; Yuan J; Hu Z; Guan W
mBio; 2021 Aug; 12(4):e0106721. PubMed ID: 34225491
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress: One potential factor for arsenite-induced increase of N
Zhao T; Li X; Sun D; Zhang Z
Environ Toxicol Pharmacol; 2019 Jul; 69():95-103. PubMed ID: 31004932
[TBL] [Abstract][Full Text] [Related]
6. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
7. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.
Feng Z; Li Q; Meng R; Yi B; Xu Q
J Cell Mol Med; 2018 May; 22(5):2558-2568. PubMed ID: 29502358
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of RNA m
Wang Z; Uddin MB; Wang PS; Liu Z; Barzideh D; Yang C
Toxicol Appl Pharmacol; 2023 Dec; 481():116764. PubMed ID: 37972769
[TBL] [Abstract][Full Text] [Related]
9. METTL3-dependent N
Chien CS; Li JY; Chien Y; Wang ML; Yarmishyn AA; Tsai PH; Juan CC; Nguyen P; Cheng HM; Huo TI; Chiou SH; Chien S
Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33579825
[TBL] [Abstract][Full Text] [Related]
10. Changes of RNA N
Chen H; Zhao T; Sun D; Wu M; Zhang Z
Toxicol In Vitro; 2019 Apr; 56():84-92. PubMed ID: 30654086
[TBL] [Abstract][Full Text] [Related]
11. N
Zhao T; Sun D; Long K; Xiong W; Man J; Zhang Q; Zhang Z
J Hazard Mater; 2024 Mar; 465():133329. PubMed ID: 38142659
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19.
Su Y; Xu R; Zhang R; Qu Y; Zuo W; Ji Z; Geng H; Pan M; Ma G
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1306-1315. PubMed ID: 33197240
[TBL] [Abstract][Full Text] [Related]
13. Reduction of Methyltransferase-like 3-Mediated RNA N6-Methyladenosine Exacerbates the Development of Psoriasis Vulgaris in Imiquimod-Induced Psoriasis-like Mouse Model.
Wang Y; Huang J; Jin H
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293529
[TBL] [Abstract][Full Text] [Related]
14. N
Gu S; Sun D; Dai H; Zhang Z
Toxicol Lett; 2018 Aug; 292():1-11. PubMed ID: 29680375
[TBL] [Abstract][Full Text] [Related]
15. METTL3 Regulates Osteoblast Differentiation and Inflammatory Response via Smad Signaling and MAPK Signaling.
Zhang Y; Gu X; Li D; Cai L; Xu Q
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892163
[TBL] [Abstract][Full Text] [Related]
16. METTL3-dependent RNA m
Zhao F; Xu Y; Gao S; Qin L; Austria Q; Siedlak SL; Pajdzik K; Dai Q; He C; Wang W; O'Donnell JM; Tang B; Zhu X
Mol Neurodegener; 2021 Sep; 16(1):70. PubMed ID: 34593014
[TBL] [Abstract][Full Text] [Related]
17. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
18. METTL3/METTL14 Transactivation and m
Feng Y; Dong H; Sun B; Hu Y; Yang Y; Jia Y; Jia L; Zhong X; Zhao R
Cell Mol Gastroenterol Hepatol; 2021; 12(3):839-856. PubMed ID: 33992834
[TBL] [Abstract][Full Text] [Related]
19. METTL3 restrains papillary thyroid cancer progression via m
He J; Zhou M; Yin J; Wan J; Chu J; Jia J; Sheng J; Wang C; Yin H; He F
Mol Ther; 2021 May; 29(5):1821-1837. PubMed ID: 33484966
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
Wang H; Xu B; Shi J
Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
